Futurity March 25, 2024
U. Michigan

Teardrop-shaped particles designed to inactivate multiple strains of the SARS-CoV-2 virus could one day complement existing treatments for COVID-19, according to a new study.

The COVID mRNA vaccines have been highly effective at preventing severe cases of the disease, but COVID-19 can still hospitalize vaccinated individuals, especially the elderly. New strains also continue to emerge, requiring constant updates to vaccines to maintain their effectiveness.

“Our immune system has to learn about a virus to generate the antibodies to fight back against infection, but by that time it may be too late for some people,” says Nicholas Kotov, a professor of chemical sciences and engineering at the University of Michigan and co-corresponding author of the study in the Proceedings of the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Provider, Public Health / COVID, Survey / Study, Trends
Why Conflicts Of Interest May Not Be As Bad As You Think (And Besides We All Have Them!)
11 drugs now in shortage
AbbVie tries to reassure investors on Humira biosimilar threat
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
This Biotech Startup Aims To Speed Up Drug Testing On Animals

Share This Article